State-of-the-art tissue engineered heart valves are not strong enough to withstand aortic blood pressure levels. When a strong and slowly degrading scaffold is used, the starting position of valvular tissue engineering is a stronger valve and seeded cells are allowed more time to create a strong extracellular matrix. A polycaprolactone knitted patch with leaflets was developed as a valvular scaffold. It was sutured into a tube and covered with fibrin gel. The opening and closing behavior and leakage of knitted scaffolds without cells were studied and compared to those of stentless porcine valves. An MTT test was performed on polycaprolactone and fibrin. A loading device was developed to study the durability of the knitted scaffold. The scaffold showed proper opening and it showed coaptation upon closing, but a 39 ؎ 3% (n ‫؍‬ 3) leakage, compared to a 8 ؎ 1% (n ‫؍‬ 3) leakage of tested porcine valves. MTT tests showed that polycaprolactone and fibrin are biocompatible materials. Durability testing of the knitted scaffold (n ‫؍‬ 1) did not show rupture after ten million loading cycles. A tissue engineering process that includes cell culture will have to show whether this scaffold, besides mechanically reliable and biocompatible, is suitable to lead to a functional, nonregurgitant, durable aortic valve.
INTRODUCTION I
N 2001, 82,000 HEART VALVES were replaced in the United States by either mechanical or biological prostheses. 1 Both of these replacements have their own drawbacks, such as thrombogenicity and poor durability, respectively. Tissue engineering (TE) is believed to provide a valve that does not have these disadvantages and is able to grow, repair, and remodel. Most of the replaced valves are mitral or aortic, so tissue engineering of the aortic valve is a challenge that, once met, will lead to a very useful product.
To create a tissue-engineered aortic valve, a strong scaffold must be the starting position. The scaffold on which cells are seeded is important in giving the specific valvular shape to the growing tissue, guiding the development of the tissue and providing support against mechanical forces. Since the opted tissue is ideally completely autologous, the scaffold should be biodegraded, leaving cells and extracellular matrix components that have developed into fully autologous tissue.
Several approaches to make a suitable aortic valve scaffold have been used: Jockenhoevel et al. 2 have made a fibrin gel valvular scaffold. Fibrin gel can be autologous and its degradation can be controlled by the addition of medium supplements. 3 Despite these advantages, a drawback is that fibrin gel has been reported to compact to up to 30% of its original size 4 or more. 5 Sodian and co-workers 6 made scaffolds out of poly-glycolic acid (PGA), poly-4-hydroxybutyrate (P4HB), and poly-3-hydroxyalkanoate-co-3-hydroxyhexanoate, all polyesters. These scaffolds all induced cellular attachment and are all biodegradable. Booth et al. 7 and Cebotari et al. 8 used decellularized porcine and human valvular matrices, respectively, as scaffolds on which to culture autologous cells. These scaffolds offer very realistic geometries, and valve characteristics are preserved provided that a proper decellularization method is used. 9 Shi et al. 10 created a scaffold out of the building blocks of the extracellular matrix of a natural valve-collagen, elastin, and glycosaminoglycans-as did Daamen and co-workers. 11 It seems a straightforward choice to use the building blocks that nature uses, but both techniques are very complex. Hoerstrup and co-workers 12 have succeeded in creating a valve that was functional in pulmonary arteries of sheep for up to 20 weeks. These valves were cultured on PGA/ P4HB scaffolds in a bioreactor before they fully developed in the sheep in which they were implanted. After explantation, the valves had the characteristic three-layered structure that is seen in natural valves. However, these semilunar valves were implanted in the low-pressure pulmonary artery instead of in the high-pressure aorta. We hypothesize that in order to create a valve that is suitable for aortic circumstances, a scaffold should be used that initially offers the TE construct mechanical properties in the range of the desired tissue. When such a scaffold material is degraded slowly, the cells that are cultured on it are given enough time to create their own strong collagen fiber structure, elastin fibers, and other mechanically important extracellular matrix components. In this way, the strength of a TE construct does not need to go through a strength gap that was caused by fast scaffold degradation on one side and insufficient extracellular matrix production on the other.
Cacciola et al. 13 have calculated the strain distribution over a stentless aortic valve leaflet. They show that diastolic strains in the stentless aortic valve are highest at the position of the commissures. At these sites formerly produced scaffold valvular leaflets are sculpted, 14 glued, 15 or welded 16 to the scaffold aortic wall.
To create a valve that is open to cellular ingrowth but load-bearing even at critical sites such as the commissures, we have developed a knitted polycaprolactone (PCL) valve, connected at the commissures by firm, evenly distributed entanglements. The knitted valve is filled and covered with fibrin gel, a naturally occurring coagulation product that can be produced from a patient's own blood. The purpose of the fibrin gel is threefold. 1) It plugs the pores and thereby reduces the leakage in the knitted scaffold. Once plugged, the scaffold closes and opens when subjected to physiologic flow conditions, enabling study of the hemodynamic behavior of the scaffold. 2) When this valvular scaffold is used for cell seeding in an actual tissue-engineering process, the fibrin is the cell carrier that is assumed to allow cells to overgrow the relatively large pores of the knitted structure.
3) The fibrin gel makes a cellular seeding process more efficient because all cells will be enclosed in the gel when being seeded instead of dripping over and through the scaffold. In this study, fibrin gel is used without cells because the goal of this study is to explore the properties of the scaffold alone.
For a valve to be accepted as implantable, one of its first requirements is to pass a durability test. ISO standards for nonactive heart valve substitutes 17 describe tests in oscillating fluid flow under various pressures, mean flows, and cycle rates. Although these standards do not apply for engineered human tissue or even TE scaffolds, the latter's mechanical properties should be equally appropriate. Since this knitted valvular scaffold, although VAN LIESHOUT ET AL. covered with fibrin gel, is still very leaky, a fluid flow would not provide enough stress on the critical sites in the valve and therefore would not be a suitable testing method. Hence we opted for an alternative mechanical testing method, i.e., inflation and deflation of a trilobular latex balloon inside the knitted scaffold.
MATERIALS AND METHODS

Knitted, fibrin-covered scaffold
A multifilament (220 dtex f44) polycaprolactone (Mw 50,000) yarn, Grilon KE-60 (gift from EMS Griltech, Domat, Switzerland) was used for the double-bed knitting (Varitex, Haarlem, Netherlands) of a 72 ϫ 35 mm rectangular patch with three leaflets knitted on as half-round pockets. Crystallinity of the multifilament yarn was determined by differential scanning calorimetry to be 66% as compared to 50% for the bulk material the yarn had been made of (bulk data obtained from the manufacturer). The patch was sutured into a tube with the same polycaprolactone yarn of which it had been knitted. The knitted valve was shaken in regularly refreshed water and soap for 24 h to dispose of the antistatic build-up layer of oils and non-crosslinked polysiloxanes on the yarn, flushed with water extensively, and shaken in 70% alcohol overnight to obtain a sterile aortic valvular scaffold. Before the fibrin gel was applied to the knitted structure, it was pulled over a stainless-steel, open-position sinus containing valve mold 15 (Fig. 1 ). Bovine fibrinogen (F-8630, 20 mg/mL; Sigma, St. Louis, MO) was dissolved in culture medium that consisted of DMEM Advanced, supplemented with 1% Glutamax (both Gibco, Paisley, United Kingdom), 10% FBS, and 0.1% gentamycin (both Biochrom, Berlin, Germany). This solution was sterile filtered (0.22 m) and mixed 1:1 with a filtered bovine thrombin (T-4648, 15 IU thrombin/mL; Sigma) solution in the same culture medium to finally obtain a fibrin solution containing 10 mg/mL fibrinogen and 7.5 IU/mL thrombin that started to gel as it was poured over the mold and taken up by the knitted structure. The polycaprolactone-fibrin valve was let to gel in an incubator for 1 h. The fibrin application-gelation procedure was repeated twice until the knit looked fully covered by fibrin. The valvular scaffold was released from its mold and put in a pulse duplicator system to be tested.
Valve exerciser-flow behavior test
The valves were tested in a physiologic flow simulator that has tunable parameters, such as pressure, stroke volume, pulse, and peripheral resistance. 18 It has the capacity to insert an endoscope, to which a high-speed camera can be attached. This was done to study the opening and closing of the valves closely. Pressure wires (RADI, Uppsala, Sweden) were inserted in the setup to measure both pre-and postvalvular pressures simultaneously during the opening and closing of the valve. A flow probe (Transonic Systems, Ithaca, NY) was attached prevalvularly to determine forward flow and backflow through the valve. The flow medium was isotonic phosphate-buffered saline (PBS, Sigma). Due to the four-fold lower viscosity of PBS with respect to blood, the pulse rate was reduced to 18.75 bpm, which is a four-fold reduction compared to a normal pulse rate of 70 bpm. This correction enabled the study of the velocity profile around the valve, which in this case is representative of that of a valve under physiologic circumstances. 19 A Medtronic freestyle stentless porcine valve was used to tune the pulse duplicator system to a physiologic flow profile and pressure of 120/80 mmHg. Consequently, three fibrin-covered knitted valves and three stentless porcine valves were subjected to these pressure and flow conditions. Forward flow through the valve was defined as the surface area underneath the positive peak of the flow plot; backflow was defined analogously for the negative part of the plot. Regurgitation was defined as the ratio of the backflow through the valve to the forward flow.
Biocompatibility-polycaprolactone and fibrin
Human vena saphena (HVS) myofibroblasts were cultured to subconfluence in a culture flask and trypsinized with a 200 mg/L EDTA-500 mg/L trypsin solution (Cambrex, Verviers, Belgium). The culture medium was DMEM Advanced, supplemented with 1% Glutamax (both Gibco), 10% FBS, and 0.1% gentamycin (both Biochrom, Berlin, Germany). Bovine thrombin (T-4648) and bovine fibrinogen (F-8630) solutions were prepared in this medium in a concentration of 15 IU/mL and 20 mg/mL, respectively. The fibrinogen and thrombin concentrations used gave a gelling speed that was low enough to enable cell mixture into the gel mixture before gelling, POLYCAPROLACTONE SCAFFOLD IN TISSUE-ENGINEERED AORTIC VALVE but high enough to start gelling during the seeding process. If gelling does not occur during the seeding process, the cell suspension drips through the scaffold and is lost. The solutions were sterile filtered.
The cells were seeded (30,000 cell/well) in triplicate into a 24-well plate in four different groups: 1) in 0.5 mL of culture medium as a positive control, 2) enclosed in 0.5 mL fibrin, 3) in 0.5 mL of culture medium on a piece of sterilized knitted polycaprolactone, and 4) enclosed in fibrin on a piece of knitted polycaprolactone. This number of cells was chosen because after 10 days of culture, cells are well below confluence and cell number increase is still linear in time, enabling proper study of the effects of the tested scaffolds on cell proliferation. This low number of cells is, however, high enough to measure a distinction in the possible effects of the scaffolds on cell proliferation. Dimensions and weights of the polycaprolactone samples were 8 ϫ 7 mm and 19 Ϯ 2 mg, respectively. For the two fibrin-enclosed groups, the HVS myofibroblasts were suspended in the thrombin solution (30,000 cell/250 L thrombin solution) before immediate 1:1 mixing with the fibrinogen solution. The cells were incubated for 45 min to allow fibrin gelation, after which 2 mL of medium was added to each well. After 10 days of static culture, an MTT test was performed.
Durability test
A cast mold in cylindrical shape with three lobes at the top was made and dipped into a latex emulsion (Wilsor, Biddinghuizen, The Netherlands). It was let to dry, and the latex balloon was peeled off, attached to a pneumatic setup (Fig. 2) , and covered with the knitted scaffold to strain the scaffold each time the balloon was inflated. The balloon was compliant and oversized, as to only transfer the stress to the scaffold and not bear the load itself. The balloon and the knitted scaffold were submerged in a PBS solution, sup- 
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plemented with 0.05% sodium azide (Merck, Darmstadt, Germany). A pressure pulse (63 bpm, 210/150 mmHg on average) was applied on the balloon until tear of the knitted scaffold or for ten million cycles (111 days). Since the failure stress of fibrin gel is negligible compared to that of the PCL yarn (kPa 20 vs. Mpa 21 range), we tested the polycaprolactone-knitted valve without the fibrin coating. After 10 million cycles, the scaffold was inspected macroscopically, and scanning electron microscopy was performed on the commissures and compared to SEM images of a similar, but nonstrained knitted scaffold. For this purpose the areas of the commissures of both valves were excised and gold sputtered (JFC-1100, JEOL USA, Peabody, MA). Microscopy was performed with a Philips XL 30 scanning electron microscope.
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Statistics
A one-way ANOVA test was performed on the MTT results; results are shown in average Ϯ standard error of the mean. The regurgitation of both fibrin-covered knitted valves and porcine stentless valves is given in average Ϯ standard error of the mean. Statistical significance is set at p Ͻ 0.05.
RESULTS
Opening and closing behavior
The visual recordings of the knitted valve and porcine valve while opening and closing were made into a short film (Fig. 3) . The cycle rate was 0.3125 Hz, which corresponds to 18.75 cycle/min. Both valves show complete coaptation upon closing, without any visible regurgitant openings. During opening the valves both show a triangular orifice, at which point none of the leaflets collides with the aortic wall. This is an important property, as some studies have reported that aortic wall colliding leaflets can become pathologic. 22, 23 Quantitative data from the physiologic flow simulator
The flow through both types of valves was monitored by the flow probe (Fig. 4) . From the representative flow versus time plots it is clear that the knitted valves show substantial leakage, with a regurgitant volume that constitutes 39 Ϯ 3% of the forward flow at an average pressure of 64 Ϯ 4 over 22 Ϯ 2 mmHg (Fig. 5A) . Calculated in the same manner, the leakage of the porcine valves is 8 Ϯ 1% at an average pressure of 119 Ϯ 4 over 74 Ϯ 4 mmHg (Fig. 5B) . It would have been appropriate to test all valves at the same pressure, but when the stroke volume is kept constant, the leakage through the knitted valve causes the pressures to decrease. Since the leaflets of the knitted scaffold coapt nicely, the leakage must have 2 . Schematic of the pneumatic setup. Air inside a cylinder is pumped in and out of a latex balloon that is fitted inside the kitted valve with a frequency of 1.05 Hz (63 bpm). The knitted valve is kept in PBS to which sodium azide is added. Pressure is measured inside the system. In addition to the pressure generated by the cylinder, extra pressure is put onto the system to create a basline pressure that is within physiological range. occurred through the pores from which the fibrin got detached. Indeed some open pores were found in the extensively tested gel-covered knitted scaffold.
Biocompatibility
Viable, attached HVS myofibroblasts were seen on the bare PCL-knitted pieces and on the fibrin-enclosed pieces of PCL, which was to be expected based on several publications. 14, 24, 25 The fibrin-cell mixed gels showed proliferated cells after 10 days, which was to be expected as well. 3, 14 MTT results show that HVS myofibroblasts, seeded either in fibrin and/or on PCL are not significantly more viable than the control group (p ϭ 0.24) (Fig. 6) .
Durability
Since the knitted scaffold did not tear under the applied load, it was taken out of the pneumatic setup after 10 million cycles (111 days). At that time the knitted scaffold was still intact and not different from the beginning of the durability test, as was established macro-and mi-POLYCAPROLACTONE SCAFFOLD IN TISSUE-ENGINEERED AORTIC VALVE croscopically. Filaments of the multifilament fibers were not ruptured anywhere in the scaffold, neither were entanglements in the commissure area torn or otherwise damaged (Fig. 7) .
DISCUSSION
The aim of this study was to develop a scaffold that was not only biologically suited to eventually tissue engineer an aortic valve, but to make it mechanically reliable for the specific shape of a valve as well. A knitted scaffold was made out of biocompatible and FDA-approved implantable materials. A durability test showed that the scaffold provided strength in its design of entangled commissures and was not altered during 10 million loading cycles. Hence, we conclude that this aim has been successfully achieved.
The opening and closing behavior of the valvular scaffold is good. In spite of the visually complete fibrin coverage of the knitted structure before testing, it has a back- flow of 39 Ϯ 3% of the forward flow. For a heart valve, this amount of regurgitation would be unacceptable, but this scaffold is not an implantable valve and is not intended to be implanted as is. The leakage is mostly due to pores from which the fibrin gel got detached. In an aortic valve tissue engineered with seeded cells onto this scaffold, cellular ingrowth and production of extracellular matrix are expected to reduce the leakage during the tissue-engineering process. In more recent experiments we have indeed made tissue-engineered aortic valves from this knitted scaffold, that were tested in the same physiologic flow simulator as that used for the bare scaffolds. These valves demonstrate considerable closing volume, but no regurgitation. More detailed results will be presented in a future paper. According to ISO standards, 17 backflow is defined as the sum of closing volume and regurgitation. In a flow versus time plot of a valve with low regurgitation, closing volume can be clearly distinguished from regurgitation. In the plots of our valvular scaffolds this was not the case; hence we chose not to make this distinction. Because of this altered definition, the leakage in the stentless porcine valves (8 Ϯ 1%) seems higher than expected.
The pneumatic durability test method that was chosen is not a typical one, which makes it difficult to compare its results with more accepted ways of testing. However, with this method the knitted scaffold is tested as a valvular structure, including its essential design of the leaflet-wall attachment. A more common flow test would not put stress on the scaffold representative of the stresses to which it would be subjected once engineered into a complete valve.
According to Chen et al., 26 polycaprolactone with a molecular weight of 30,000 was reduced in molecular weight by 24% during 5 weeks of degradation under pH 7.4 in the presence of lipases. Besides the aforementioned advantages of mechanical integrity of the knitted scaf-VAN LIESHOUT ET AL.
fold, these findings indicate that the polycaprolactone knit is also expected to stay this reliable because of its relatively long degradation period. This longer degradation period of PLC compared to many other biodegradable polyesters will allow seeded cells more time to create a strong extracellular matrix. However, it can also form a major disadvantage; for example, when used for tissue engineering and implanted in growing infants, the patients might outgrow their valvular scaffolds. For this possible problem a solution could be to pretreat the scaffold with a strong acid or base to start the autocatalysis of the degradation process. This too will be dealt with in future work. 
